Trending Topic

11 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Lung cancer is the second most common type of cancer worldwide and in the USA, with its incidence varying depending on geographic and socioeconomic factors.1–3 According to data from the Global Cancer Observatory: Cancer Incidence, Mortality and Prevalence (GLOBACAN) database, an estimated 2.48 million new cases of lung cancer were reported in 2022.4,5 Although lung cancer rates in the […]

CME Accredited Learning

Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.

touchONCOLOGY

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
54 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchSYMPOSIUM
Prof. Marina Garassino, Prof. Jaruskha Naidoo, Prof. David Planchard

In this symposium, three lung cancer specialists share their insights on TROP2-targeted ADCs in NSCLC

38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Two experts discuss evolving immunotherapy standards of care in advanced/recurrent endometrial cancer.

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Véronique Diéras, Dr Scott Edwards, Dr Kayla Freeman, Mrs Lesley Turner

A multidisciplinary team and a patient advocate discuss antibody–drug conjugate (ADC) related toxicities in metastatic breast cancer.

36 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Alicia Morgans, Prof. Albrecht Stenzinger, Dr Grace Cullen, Mr Tony Collier

A multidisciplinary team and a patient advocate discuss use of PARP inhibitors in mCRPC

35 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch two experts discuss HPV-related disease, vaccination scheduling and strategies to increase uptake.

15 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Expert insights on new and emerging approaches to optimize the management of steroid-refractory cGvHD.

55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS
Prof. Katja Weisel, Dr Nisha Joseph, Prof. Roman Hájek

Three experts discuss data presented at ASH 2024 on BCMA-targeting agents in multiple myeloma.

40 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Dr Hanny Al-Samkari, Dr Drew Provan, Dr Barbara Skopec

Three expert haematologists discuss current and emerging treatments for ITP as well as the disease burden.

29 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr David S Hong, Dr Eileen M O’Reilly, Dr Rebecca S Heist

Experts discuss the role of RAS mutations in solid tumours and how they may be targeted to improve outcomes.

Society & Congress Partners

touchONCOLOGY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

View All
20 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch a lung cancer expert discuss the latest data for ADCs in NSCLC and their implications for clinical practice.

90 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchSYMPOSIUM
Prof. Cindy Neunert, Prof. David Kuter, Dr María Eva Mingot Castellano

Leading experts discuss the impact of ITP on patients and review current and emerging treatment strategies.

35 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS
Dr AeRang Kim, Dr Rebecca Brown, Dr Kaleb Yohay

Three experts share insights into the treatment and care of patients with NF1 from childhood to adulthood.

36 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Laura Mertens; Prof. Thomas Powles; Ms Lindsay Diamond

An oncologist, urologist and oncology nurse consider the use of perioperative immunotherapy in MIBC.

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Teresa Amaral, Prof. Piotr Rutkowski, Dr Tina Hieken

Hear expert insights on recurrence risk in early-stage melanoma and possible treatment approaches

99 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCLINICAL PERSPECTIVES
Dr Helena Yu, Dr Antonio Passaro, Dr Aaron Lisberg, Dr Sara Pilotto, Ms Jackie Fenemore, Prof. Egbert Smit

Experts provide insights on tailoring treatment in patients with EGFR-mutant and wildtype NSCLC.

39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Lizza Hendriks, Dr Jacob Sands, Prof. Suresh Senan

A multidisciplinary team discusses the role of immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC).

55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Xiuning Le, Dr Christine Argento, Dr Sandra Cuellar, Ms Stephanie McDonald, Prof. Albrecht Stenzinger

A multidisciplinary team of specialists discuss the use of targeted therapies for NSCLC with MET alterations.

15 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch an expert in lung cancer discuss the treatment options for patients with early-stage EGFR-mutant NSCLC

Load More...

All touchIME CME activities are accredited. Learners can claim ACCME, ANCC, ACPE or EBAC credits upon completion of the activities. This content is for healthcare professionals only.

Close Popup